XBiotech Inc

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative -6.54 M-6.72 M-5.99 M-4.26 M-22.95 M -39.92 M Flussi di cassa derivanti dalle attività di investimento -84 K-94 K-51 K-110 K-34 K -289 K Liquidità derivante dalle attività di finanziamento 283 K-10.25 M000 -10.25 M Liquidità libera -6.62 M-6.81 M-6.04 M-4.37 M-22.99 M -40.21 M

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

XBIT

Financials

XBiotech Inc

Notizie

XBiotech shareholders approve board nominees and key proposals at annual meeting

XBiotech appoints Thomas Kündig and Craig Rademaker to board of directors